Filter
212
Filtered Results: 212
Text search:
dyslipidemia
Featured
Recommendations
17
New Publications
64
Language
Document type
No document type
113
Guidelines
46
Studies & Reports
39
Strategic & Response Plan
5
Manuals
4
Training Material
3
Infographics
1
Fact sheets
1
Countries / Regions
India
17
Global
13
Paraguay
12
Philippines
10
Chile
8
Indonesia
8
Kenya
7
Latin America and the Carribbean
5
Venezuela
4
Tanzania
4
South Africa
4
Ethiopia
4
Mozambique
3
Western and Central Europe
3
North America
3
Brazil
3
Colombia
2
Benin
2
Nigeria
2
Peru
2
Africa
2
Asia
2
Argentina
2
Zambia
2
Eswatini/ Swaziland
2
Nepal
1
El Salvador
1
Ghana
1
Malawi
1
USA
1
Congo, Democratic Republic of
1
West and Central Africa
1
East and Southern Africa
1
Bolivia
1
Bangladesh
1
Eastern Europe
1
Namibia
1
Authors & Publishers
Publication Years
Category
Countries
105
Clinical Guidelines
39
Public Health
37
Women & Child Health
8
Capacity Building
7
Toolboxes
NCDs
45
HIV
17
Mental Health
13
COVID-19
5
Planetary Health
4
Pharmacy
4
Refugee
2
Disability
1
Caregiver
1
AMR
1
Brussels, December 16. 2016
PLOS ONE | https://doi.org/10.1371/journal.pone.0196380 May 15, 2018
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
Background
Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease.
Main text
While improving the availability and delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovasc...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, prsents current World Health Organization (WHO) guidance on the safety of various contraceptive e-
m...
Clinical Practice Guidelines and Clinical Pathway for Therapy and Management of Heart Disease and Blood Vessels in Indonesia
Guidelines for Therapy and Management of Hypertension in Cardiovascular Disease in Indonesia
The WHO Guidelines on risk reduction of cognitive decline and dementia provide evidence-based recommendations on lifestyle behaviours and interventions to delay or prevent cognitive decline and dementia. These WHO Guidelines are an important tool for health care providers as well as governments, pol...
Las enfermedades no transmisibles (ENT) suelen ser condiciones de salud de larga duración, resultado de determinantes sociales, factores genéticos, fisiológicos, ambientales y conductuales. Debido a la adquisición de hábitos poco saludables y al importante cambio demográfico, que evidencia un ...
Este Manual pretende ser un documento de referencia para el desarrollo de Seguimiento Farmaco-
terapéutico a usuarios que se atiendan en centros de salud ambulatorios del país. Se entrega a los
Químicos Farmacéuticos locales una metodología estandarizada y probada en Chile como base para
el ...
Basado en la Metodología POLARIS de Seguimiento Farmacoterapéutico, desarrollado por
Facultad de Química de la Pontificia Universidad Católica de Chile.
